Notice: This company has been marked as potentially delisted and may not be actively trading. Immuron (IMRN) News Today Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsCompetitorsHeadlinesShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Immuron Limited Issues New Unquoted Equity SecuritiesDecember 9, 2024 | tipranks.comImmuron Limited Director Acquires 1,000,000 OptionsDecember 9, 2024 | tipranks.comImmuron Limited Director Increases Stake with New OptionsDecember 9, 2024 | tipranks.comImmuron Limited Director Acquires Unlisted OptionsDecember 9, 2024 | tipranks.comImmuron CEO, Steven Lydeamore to Present at the Small Cap Growth Virtual Investor Conference December 5thDecember 2, 2024 | globenewswire.comImmuron CEO, Steven Lydeamore presentation to 21st Virtual Investor Summit Microcap EventNovember 22, 2024 | finance.yahoo.comImmuron CEO, Steven Lydeamore presentation to 21st Virtual Investor Summit Microcap EventNovember 21, 2024 | globenewswire.comImmuron Limited Secures Approval on Key AGM ResolutionsNovember 18, 2024 | markets.businessinsider.comImmuron Limited Issues New Unquoted Performance RightsOctober 29, 2024 | markets.businessinsider.comImmuron CEO, Steven Lydeamore participation in Maxim Virtual Healthcare ConferenceOctober 16, 2024 | globenewswire.comImmuron Limited: Immuron Travelan continued strong sales growthOctober 15, 2024 | finanznachrichten.deImmuron Travelan® continued strong sales growthOctober 15, 2024 | globenewswire.comImmuron turns in strong performance for Travelan® in September quarter, expands globallyOctober 14, 2024 | au.investing.comImmuron making inroads into the international market with flagship assets Travelan and IMM-529October 11, 2024 | au.investing.comImmuron (NASDAQ:IMRN) Stock Quotes, Forecast and News SummaryOctober 4, 2024 | benzinga.comNMRC Reports Results for Campylobacter Controlled Human Infection Model StudyOctober 4, 2024 | globenewswire.comTraveler's Diarrhea Therapeutics Pipeline Market Report 2024 Featuring Immuron, Scandinavian Biopharma, and Sigmoid PharmaSeptember 19, 2024 | globenewswire.comImmuron Plans Phase 2 Trial for IMM-529 following FDA reviewSeptember 5, 2024 | globenewswire.comImmuron Limited (IMRN) Stock Price, News, Quote & History - Yahoo FinanceAugust 30, 2024 | ca.finance.yahoo.comImmuron Limited (IMRN)August 25, 2024 | finance.yahoo.comImmuron Announces New U.S. Department of Defense Research Award for Naval Medical Research Command and Walter Reed Army Institute of Research to advance Travelan®August 16, 2024 | globenewswire.comBond investing making a comeback on rate cut forecasts: PanelAugust 16, 2024 | uk.finance.yahoo.comAI is being 'built into everything we're doing': Lenovo execAugust 16, 2024 | uk.finance.yahoo.comImmuron CEO, Steven Lydeamore to present at the Emerging Growth ConferenceAugust 15, 2024 | globenewswire.comImmuron CEO, Steven Lydeamore to host webinar on MarketOpen Direct ConnectAugust 7, 2024 | globenewswire.comImmuron Limited (IMC.AX)August 4, 2024 | finance.yahoo.comImmuron requests pre-IND meeting for IMM-529 with FDA filingJuly 2, 2024 | globenewswire.comImmuron CEO, Steven Lydeamore to present at the Emerging Growth ConferenceJune 5, 2024 | globenewswire.comImmuron CEO Steven Lydeamore to present at Peak Sky HighMay 31, 2024 | globenewswire.comImmuron Board ChangesMay 31, 2024 | globenewswire.comImmuron Limited to Present at the Emerging Growth ConferenceMay 7, 2024 | globenewswire.comImmuron Director ResignationMay 3, 2024 | globenewswire.comImmuron Limited (IMRN) Interactive Stock Chart - Yahoo FinanceApril 15, 2024 | finance.yahoo.comImmuron to host Live Virtual EventApril 15, 2024 | globenewswire.comImmuron Limited: Immuron Travelan sales continued strong growthApril 10, 2024 | finanznachrichten.deImmuron gains after Travelan sales updateApril 10, 2024 | msn.comImmuron Travelan® sales continued strong growthApril 10, 2024 | globenewswire.comImmuron Limited (IMRN) Latest Stock News & Headlines - Yahoo FinanceMarch 27, 2024 | ca.finance.yahoo.comImmuron Ltd ADR (IMRN)March 22, 2024 | investing.comImmuron surges after mid-stage data for antidiarrheal medMarch 7, 2024 | msn.comImmuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the USMarch 7, 2024 | globenewswire.comASX Health Stocks: Immuron leaps 80pc after announcing that Travelan trials will move to Phase 3March 7, 2024 | msn.comTrading was temporarily halted for "IMRN" at 07:03 PM with a stated reason of "News pending."March 5, 2024 | marketbeat.comImmuron Stock (NASDAQ:IMRN) Dividends: History, Yield and DatesFebruary 22, 2024 | benzinga.comImmuron Presentation Australian Biologics Festival 2024February 21, 2024 | globenewswire.comImmuron Limited: Immuron achieves record Travelan salesFebruary 13, 2024 | finanznachrichten.deImmuron achieves record Travelan® salesFebruary 13, 2024 | finance.yahoo.comImmuron Limited: Immuron achieves record half yearly Travelan salesJanuary 16, 2024 | finanznachrichten.deImmuron achieves record half yearly Travelan® salesJanuary 16, 2024 | finance.yahoo.comASX Health Stocks: Immuron chalks up record half for travelers’ diarrhoea medicine, TravelanJanuary 15, 2024 | msn.com Get Immuron News Delivered to You Automatically Sign up to receive the latest news and ratings for IMRN and its competitors with MarketBeat's FREE daily newsletter. Email Address We recommended Palantir in 2021, now we’re recommending this... (Ad)My research indicates there is only one investment that can meet AI's unprecedented demand for energy. Click to get the name and ticker symbol IMRN Media Mentions By Week IMRN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMRN News Sentiment▼0.000.60▲Average Medical News Sentiment IMRN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMRN Articles This Week▼01▲IMRN Articles Average Week Get Immuron News Delivered to You Automatically Sign up to receive the latest news and ratings for IMRN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies XCUR News Today PRLD News Today ALRN News Today BIVI News Today RFL News Today VIRI News Today GANX News Today SCYX News Today RLYB News Today QTTB News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IMRN) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immuron Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Immuron With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
